Top Markets
#1 ADO Protocol ADO Protocol +337.69%
#2 GoPlus Security GoPlus Security +57.08%
#3 Tutorial Tutorial +44.03%
#4 Starpower Starpower +38.64%
#5 Nockchain Nockchain +38.56%
#6 The Black Bull The Black Bull +28.94%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.07%
#8 GAIB AID GAIB AID +24.67%
#9 Fake World Assets Fake World Assets +22.34%
#10 OpenEden OpenEden +20.92%
Coin of the day
ADO Protocol ADO Protocol
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Traws Pharma, Inc. Traws Pharma, Inc.

Traws Pharma, Inc.

TRAW
Pozycja w akcjach #33205
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage,... Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is presently in Phase 1/2 clinical trials in cancer patients, being evaluated both independently and in conjunction with letrozole, with the goal of establishing the recommended Phase 2 dosage for future work in endometrial cancer. The company is also investigating oral rigosertib, exploring its potential as a standalone therapy or in combination regimens across diverse cancer types. Originally established in 1998 as Onconova Therapeutics, Inc., the company officially adopted its current name, Traws Pharma, Inc., in April 2024. Its corporate headquarters are located in Newtown, Pennsylvania.
Cena akcji
$0.54
Kapitalizacja rynkowa
$8.22M
Zmiana (1 dzień)
-5.43%
Zmiana (1 rok)
-64.24%
Kraj
US
Handel Traws Pharma, Inc. (TRAW)

Kategoria

Healthcare
Historia ceny akcji dla Traws Pharma, Inc. (TRAW)
Najwyższa cena zamknięcia: $0.55 dnia 2026-08-01

Najniższa cena zamknięcia: $1.18M dnia 2013-07-01
Historia cen akcji firmy Traws Pharma, Inc. od 2013 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -7.87%
2025 -73.19%
2024 -62.45%
2023 -1.12%
2022 -73.33%
2021 -51.96%
2020 16.11%
2019 -88.57%
2018 -87.09%
2017 -39.73%
2016 -78.39%
2015 -71.56%
2014 -71.82%
2013 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $513.73 30.79%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $993.55 51.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 7.19%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE